spacer
spacer

PDBsum entry 2rcx

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Hydrolase PDB id
2rcx

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
358 a.a. *
Ligands
SM4-PO4
PO4
SM4
Waters ×482
* Residue conservation analysis
PDB id:
2rcx
Name: Hydrolase
Title: Ampc beta-lactamase in complex with (1r)-1-(2-thiophen-2-yl- acetylamino)-1-(3-(2-carboxyvinyl)-phenyl) methylboronic acid
Structure: Beta-lactamase. Chain: a, b. Synonym: cephalosporinase. Engineered: yes
Source: Escherichia coli. Organism_taxid: 562. Gene: ampc, ampa. Expressed in: escherichia coli k12. Expression_system_taxid: 83333.
Resolution:
2.00Å     R-factor:   0.176     R-free:   0.219
Authors: F.Morandi,S.Morandi,F.Prati,B.K.Shoichet
Key ref: S.Morandi et al. (2008). Structure-based optimization of cephalothin-analogue boronic acids as beta-lactamase inhibitors. Bioorg Med Chem Lett, 16, 1195-1205. PubMed id: 17997318 DOI: 10.1016/j.bmc.2007.10.075
Date:
20-Sep-07     Release date:   27-Nov-07    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P00811  (AMPC_ECOLI) -  Beta-lactamase from Escherichia coli (strain K12)
Seq:
Struc:
377 a.a.
358 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.3.5.2.6  - beta-lactamase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

      Pathway:
Penicillin Biosynthesis and Metabolism
      Reaction: a beta-lactam + H2O = a substituted beta-amino acid
      Cofactor: Zn(2+)

 

 
DOI no: 10.1016/j.bmc.2007.10.075 Bioorg Med Chem Lett 16:1195-1205 (2008)
PubMed id: 17997318  
 
 
Structure-based optimization of cephalothin-analogue boronic acids as beta-lactamase inhibitors.
S.Morandi, F.Morandi, E.Caselli, B.K.Shoichet, F.Prati.
 
  ABSTRACT  
 
Boronic acids have proved to be promising selective inhibitors of beta-lactamases, acting as transition state analogues. Starting from a previously described nanomolar inhibitor of AmpC beta-lactamase, three new inhibitors were designed to gain interactions with highly conserved residues, such as Asn343, and to bind more tightly to the enzyme. Among these, one was obtained by stereoselective synthesis and succeeded in placing its anionic group into the carboxylate binding site of the enzyme, as revealed by X-ray crystallography of the complex inhibitor/AmpC. Nevertheless, it failed at improving affinity, when compared to the lead from which it was derived. The origins of this structural and energetic discrepancy are discussed.
 

Literature references that cite this PDB file's key reference

  PubMed id Reference
20394454 C.Bebrone, P.Lassaux, L.Vercheval, J.S.Sohier, A.Jehaes, E.Sauvage, and M.Galleni (2010).
Current challenges in antimicrobial chemotherapy: focus on ß-lactamase inhibition.
  Drugs, 70, 651-679.  
19925018 S.M.Drawz, M.Babic, C.R.Bethel, M.Taracila, A.M.Distler, C.Ori, E.Caselli, F.Prati, and R.A.Bonomo (2010).
Inhibition of the class C beta-lactamase from Acinetobacter spp.: insights into effective inhibitor design.
  Biochemistry, 49, 329-340.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time.

 

spacer

spacer